FI20000303A
FI20000303A0
(en)
|
2000-02-14 |
2000-02-14 |
Compounds Useful for the Treatment or Prevention of Alpha-2B Adrenoceptor Mediated Disease
|
IL15101701A
IL151017A0
(en)
|
2000-02-11 |
2001-02-07 |
Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
|
GE4893A
GEP20043356B
(en)
|
2000-02-11 |
2001-02-07 |
Compounds Useful For Treatment or Prevention of Diseases Mediated By Alpha- 2B-Adrenoceptor
|
PCT/FI2001/000105
WO2001058454A1
(en)
|
2000-02-11 |
2001-02-07 |
Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
|
MXPA02007454A
MXPA02007454A
(en)
|
2000-02-11 |
2001-02-07 |
Compounds useful for the treatment or prevention of a disease mediated by the alpha 2b adrenoceptor.
|
EA200200846A
EA200200846A1
(en)
|
2000-02-11 |
2001-02-07 |
CONNECTIONS USEFUL FOR THE TREATMENT OR PREVENTION OF DISEASES MEDIATED BY ALPHA-2B-ADRENOCEPTOR
|
KR1020027010329A
KR20020080413A
(en)
|
2000-02-11 |
2001-02-07 |
Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
|
BR0108221-3A
BR0108221A
(en)
|
2000-02-11 |
2001-02-07 |
Use of a selective alpha-2b-adrenoceptor antagonist for the manufacture of a pharmaceutical preparation and method for treating or preventing an alpha-2b-adrenoceptor-mediated disease in a mammal
|
SK1147-2002A
SK11472002A3
(en)
|
2000-02-11 |
2001-02-07 |
Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
|
CZ20022884A
CZ20022884A3
(en)
|
2000-02-11 |
2001-02-07 |
Compounds useful for treating or prophylaxis of diseases mediated by alpha-2B- adrenoceptors
|
CA002399421A
CA2399421A1
(en)
|
2000-02-11 |
2001-02-07 |
Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
|
PL01357872A
PL357872A1
(en)
|
2000-02-11 |
2001-02-07 |
Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
|
HU0300032A
HUP0300032A3
(en)
|
2000-02-11 |
2001-02-07 |
Use of compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoreceptor for preparation of pharmaceutical composition
|
JP2001557564A
JP2003522148A
(en)
|
2000-02-11 |
2001-02-07 |
Compounds useful for treating or preventing diseases mediated by alpha-2B-adrenergic receptor
|
EP01907585A
EP1253926A1
(en)
|
2000-02-11 |
2001-02-07 |
Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
|
EEP200200435A
EE200200435A
(en)
|
2000-02-11 |
2001-02-07 |
Selective alpha-2B adrenoceptor antagonists and their use
|
NZ520500A
NZ520500A
(en)
|
2000-02-11 |
2001-02-07 |
Sulfonamides useful for the treatment or prevention of a disease i.e. vascular and coronary heart disease mediated by the alpha-2B-adrenoceptor
|
AU35510/01A
AU780802B2
(en)
|
2000-02-11 |
2001-02-07 |
Compounds useful for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor
|
YU59102A
YU59102A
(en)
|
2000-02-11 |
2001-02-07 |
COMPOUNDS USEFUL FOR THE TREATMENT OR PREVENTION OF A DISEASE MEDIATED BY THE ALPHA-2β-ADRENOCEPTOR
|
MYPI20010579A
MY133957A
(en)
|
2000-02-11 |
2001-02-09 |
"compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor"
|
IS6476A
IS6476A
(en)
|
2000-02-11 |
2002-07-19 |
Compounds useful for the treatment or prevention of a disease occurring through alpha-2B-adrenoceptor receptors
|
NO20023773A
NO20023773L
(en)
|
2000-02-11 |
2002-08-09 |
Compounds useful for treating or preventing a disease mediated by alpha-2B adrenoceptor
|
HRP20020746
HRP20020746A2
(en)
|
2000-02-11 |
2002-09-11 |
Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
|